Chemotherapy-induced Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Chemotherapy-induced Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Use of Aromatherapy to Reduce Symptom Burden [Phase 2]
Phase 2 clinical trial evaluated aromatherapy to reduce symptom burden in patients with anxiety and chemotherapy-induced nausea and vomiting…
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer [Phase 3]
Phase 3 clinical trial investigating electroacupuncture plus a four-drug antiemetic regimen (including olanzapine) for chemotherapy-induced …
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer [Phase 3]
Phase 3 trial investigating thalidomide for chemotherapy-related nausea and vomiting in pancreatic cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Low Dose Aprepitant for Patients Receiving Carboplatin [Phase 2]
Phase 2 trial investigating low-dose aprepitant for chemotherapy-induced nausea and vomiting in patients receiving carboplatin has been term…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapy [Phase 2]
A Phase 2 clinical trial update focused on preventing breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Effect of Inhaled Aromatherapy on Chemo-Induced Nausea Vomiting (NCVI): CINVAROM (Chemotherapy Induced Nausea Vomiting and AROMatherapy) [Phase 2]
Phase 2 clinical trial evaluating inhaled aromatherapy for chemotherapy-induced nausea and vomiting (CINV) called CINVAROM; the study is com…
-
CLINICAL_TRIALS trial_result · 2023-07-28Clinical Trial Update: Safety Study of Repeat Doses of SUSTOL in Adults [Phase 4]
Phase 4 safety study assessing repeat dosing of SUSTOL in adults with chemotherapy-induced nausea and vomiting.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Olanzapine for Nausea/Vomiting Prophylaxis in Recipients of Hematopoietic Stem Cell Transplants [Phase 3]
Phase 3 trial assessing olanzapine for nausea and vomiting prophylaxis in recipients of hematopoietic stem cell transplants has completed wi…
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer [Phase 4]
Phase 4 trial comparing intravenous versus oral 5-HT3 antagonists combined with NK-1 receptor antagonists for prevention of chemotherapy-ind…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: A Randomized Controlled Trial of SP-01 (Granisetron Transdermal Delivery System) in Chemotherapy-induced Nausea and Vomiting [Phase 3]
Phase 3 randomized trial of SP-01 Granisetron Transdermal Delivery System for chemotherapy-induced nausea and vomiting has been completed.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Aprepitant Triple Therapy for the Prevention of CINV in Nondrinking and Young Women Who Received Moderately Emetogenic Chemotherapy [Phase 3]
Phase 3 clinical trial evaluating aprepitant triple therapy to prevent chemotherapy-induced nausea and vomiting in nondrinking and young wom…
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC [Phase 3]
Phase 3 trial comparing Buccal Film to IV Palonosetron for prevention of chemotherapy-induced nausea and vomiting in cancer patients receivi…
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Olanzapine or Dexamethasone, With 5-HT3 RA and NK-1 RA, to Prevent CINV [Phase 3]
A Phase 3 trial evaluating olanzapine or dexamethasone, with a 5-HT3 receptor antagonist and an NK-1 receptor antagonist, for preventing che…
-
CLINICAL_TRIALS trial_result · 2022-07-28Clinical Trial Update: Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents [Phase 3]
A Phase 3 clinical trial evaluating low-dose olanzapine for preventing chemotherapy-induced nausea and vomiting in children and adolescents.
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy [Phase 2]
A Phase 2 trial evaluating pantoprazole as a prophylaxis against delayed chemotherapy-induced nausea and vomiting in patients receiving brea…
-
CLINICAL_TRIALS trial_result · 2022-05-20Clinical Trial Update: Capsaicin to Prevent Delayed Chemotherapy Induced Nausea and Vomiting (CapCIN) [Phase 2]
Phase 2 trial update for capsaicin to prevent delayed chemotherapy-induced nausea and vomiting (CapCIN) has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Granisetron Transdermal Patch for Prophylaxis of Nausea and Vomiting in Patients Receiving Oral Anticancer Agents [Phase 2]
Phase 2 clinical trial update evaluating granisetron transdermal patch for prevention of chemotherapy-induced nausea and vomiting in patient…
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: Granisetron Transdermal Patch System for Prevention of CINV by CapeOX [Phase 2]
Phase 2 trial update for granisetron transdermal patch to prevent chemotherapy-induced nausea and vomiting with CapeOX regimen.
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer [Phase 2]
Phase 2 trial evaluating olanzapine, netupitant, and palonosetron for controlling nausea and vomiting induced by highly emetogenic chemother…
-
CLINICAL_TRIALS trial_result · 2022-01-21Clinical Trial Update: Olanzapine for Chemotherapy-induced Nausea and Vomiting Prophylaxis [Phase 3]
Phase 3 trial update evaluating olanzapine for chemotherapy-induced nausea and vomiting prophylaxis has completed.
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin [Phase 2, Phase 3]
Phase 2/3 trial update evaluating safety and antiemetic efficacy of Akynzeo with dexamethasone during radiotherapy plus weekly cisplatin in …
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045) [Phase 4]
Phase 4 pediatric trial MK-0517-045 evaluates the safety of a three-day fosaprepitant regimen to prevent chemotherapy-induced nausea and vom…
-
CLINICAL_TRIALS trial_result · 2021-08-04Clinical Trial Update: Evaluate Bioequivalence of Palonosetron (0.25mg/5mL) [Phase 4]
Phase 4 study evaluating bioequivalence of Palonosetron 0.25 mg per 5 mL for chemotherapy-induced nausea and vomiting prophylaxis has comple…
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: Aprepitant Without Steroid in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Colorectal Cancer [Phase 3]
Phase 3 trial investigating aprepitant without steroid for preventing chemotherapy-induced nausea and vomiting in colorectal cancer patients…
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer [Phase 4]
Phase 4 trial update investigating olanzapine for prevention and treatment of chemotherapy-induced nausea and vomiting in patients with lung…